Experimental strategies to manipulate the cellular levels of the multifunctional factor CTCF

Methods in Molecular Biology

Volumn 1165, Issue , 2014, Pages 53-69

  González Buendía, Edgar ^a   Pérez Molina, Rosario ^a   Ayala Ortega, Erandi ^a   Guerrero, Georgina ^a   Recillas Targa, Félix ^a  

^a NONE

Author keywords

CTCF; Electroporation; Fluorescent cytometry; Inducible vectors; Interference RNA; Lentivirus; Lipofection

Indexed keywords

MICRORNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR CTCF; ANTIINFECTIVE AGENT; CCCTC-BINDING FACTOR; PHOTOPROTEIN; REPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL FUNCTION; CHROMATIN; CONTROLLED STUDY; DNA TRANSFER; DOWN REGULATION; ELECTROPORATION; FEMALE; FLOW CYTOMETRY; GENE CONTROL; GENE SILENCING; HOMEOSTASIS; HUMAN; HUMAN CELL; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; RNA INTERFERENCE; STABLE TRANSFECTION; TITRIMETRY; VIRUS EXPRESSION; ANTIBIOTIC RESISTANCE; CELL LINE; DEFICIENCY; GENETIC PROCEDURES; GENETIC TRANSDUCTION; GENETICS; HEK293 CELL LINE; HELA CELL LINE;

LENTIVIRUS;

ANTI-BACTERIAL AGENTS; CELL LINE; DOWN-REGULATION; DRUG RESISTANCE, BACTERIAL; FLOW CYTOMETRY; GENE KNOCKDOWN TECHNIQUES; GENETIC TECHNIQUES; HEK293 CELLS; HELA CELLS; HUMANS; LENTIVIRUS; LUMINESCENT PROTEINS; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSDUCTION, GENETIC;

EID: 84922069941     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0856-1_5     Document Type: Article

References (46)

1. Boudreau RL, Davidson BL (2012) Generation of hairpin-based RNAi vectors for biological and therapeutic applications. Methods Enzymol 507:275–296
2. Phillips JE, Corces VG (2009) CTCF: master weaver of the genome. Cell 137:1194–1211
3. Herold M, Bartkuhn M, Renkawitz R (2012) CTCF: insights into insulator function during development. Development 139:1045–1057
4. Lobanenkov VV, Nicolas RH, Adler VV, Paterson H, Klenova EM, Polotskaja AV et al (1990) A novel sequence-specifi c DNA binding protein which interacts with three regulatory spaced direct repeats of the CCCTC-motif in the 5′ fl anking sequence of the chicken c-myc gene. Oncogene 5:1743–1753
5. Philippova GN, Qi CF, Ulmer JE, Moore JM, Wards MD, Hu YJ et al (2002) Tumorassociated zinc fi nger mutations in the CTCF transcription factor selectively alter its DNAbinding specifi city. Cancer Res 62:48–52
6. Ohlsson R, Lobanenkov V, Klenova E (2010) Does CTCF mediate between nuclear organization and gene expression? BioEssays 32:37–50
7. Valadez-Graham V, Razin SV, Recillas-Targa F (2004) CTCF-dependent enhancer blocker at the upstream region of the chicken α-globin gene domain. Nucleic Acids Res 32:1354–1362
8. Engel N, West AG, Felsenfeld G, Bartolomei MS (2004) Antagonism between DNA hypermethylation and enhancer-blocking activity at the H19 DMD is uncovered by CpG mutations. Nat Genet 36:883–888
9. DeLa Rosa-Velázquez IS, Rincón-Arano H, Benítez-Bribiesca L, Recillas-Targa F (2007) Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF. Cancer Res 67:2577–2585
10. El-Kady A, Klenova E (2005) Regulation of the transcription factor, CTCF, by phosphorylation with protein kinase CK2. FEBS Lett 579:1424–1434
11. Docquier F, Jita GX, Farrar D, Jat P, O’Hare M, Chernukhin I et al (2009) Decreased poly(ADP-ribosyl)ation of CTCF, a transcription factor, is associated with breast cancer phenotype and cell proliferation. Clin Cancer Res 15:5762–5771
12. Kitchen NS, Schoenherr CJ (2010) Sumoylation modulates a domain in CTCF that activates transcription and decondenses chromatin. J Cell Biochem 11:665–675
13. MacPherson MJ, Beatty LG, Zhoi W, Du M, Sdowski PD (2009) The CTCF insulator protein posttranslationally modifi ed by SUMO. Mol Cell Biol 29:714–725
14. Docquier F, Farrar D, D’Arcy V, Chernukhin I, Robinsin AF, Loukinov D et al (2005) Heightened expression of CTCF in breast cancer cells is associated with resistance to apoptosis. Cancer Res 65:5112–5122
15. Soshnikova N, Montavon T, Leleu M, Galjart N, Duboule D (2010) Functional analysis of CTCF during mammalian limb development. Dev Cell 19:819–830
16. Delgado-Olguín P, Brand-Arzamendi K, Scott IC, Jungblut B, Stainier DY, Bruneau BG et al (2011) CTCF promotes muscle differentiation by modulating the activity of myogenic regulatory factors. J Biol Chem 286:12483–12484
17. Liu Z, Scannell DR, Eisen MB, Tjian R (2011) Control of embryonic stem cell lineage commitment by core promoter factor, TAF3. Cell 146:720–731
18. Fiorentino FP, Giordano A (2011) The tumor suppressor role of CTCF. J Cell Physiol 227: 479–492
19. Recillas-Targa F, DeLa Rosa-Velázquez IA, Soto-Reyes E (2011) Insulation of tumor suppressor genes by the nuclear factor CTCF. Biochem Cell Biol 89:479–488
20. Barkess G, West AG (2012) Chromatin insulator elements: establishing barriers to set heterochromatin boundaries. Epigenomics 4:67–80
21. Burgess-Beusse B, Farrell C, Gaszner M, Litt M, Mutskov V, Recillas-Targa F et al (2002) The insulation of genes from external enhancers and silencing chromatin. Proc Natl Acad Sci USA 4:16433–16437
22. Pikaart M, Recillas-Targa F, Felsenfeld G (1998) Loss of transcriptional activity of the transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators. Genes Dev 12:2852–2862
23. Recillas-Targa F, Valadez-Graham V, Farrell CM (2004) Prospects and implications of using chromatin insulators in gene therapy and transgenesis. BioEssays 26:796–807
24. Furlan-Magaril M, Rebollar E, Guerrero G, Fernández A, Moltó E, González-Buendía E et al (2011) An insulator embedded in the Chicken α-globin locus regulates chromatin domain confi guration and differential gene expression. Nucleic Acids Res 39:89–103
25. Splinter E, Heath H, Kooren J, Palstra RJ, Klaus P, Grosveld F et al (2006) CTCF mediates long-range chromatin loop and local histone modifi cation in the β-globin locus. Genes Dev 20:2349–2354
26. Kurukuti S, Tiwari VK, Tavoosidana G, Pugacheva E, Murrell A, Zhao Z et al (2006) CTCF binding at the H19 imprinting control region mediates maternally inherited higherorder chromatin conformation to restrict enhancer access to Igf2. Proc Natl Acad Sci USA 103:10684–10689
27. van Bortle K, Corces VG (2013) The role of chromatin insulators in nuclear architecture and genome function. Curr Opin Genet Dev 23(2):212–218
28. Guelen L, Pagie L, Brasset E, Meuleman W, Faza MB, Talhout W et al (2008) Domain organization of human chromosomes revealed by mapping the nuclear lamina interactions. Nature 453:948–951
29. Bonetta L (2005) The inside scoop-evaluating gene delivery methods. Nat Methods 2: 875–883
30. Sambrook J, Russell DW. Molecular cloning, A laboratory manual, 2(4): 1–15.
31. Hughes D, Marendy E, Dickerson C, Yetming K, Sample C, Sample J (2012) Contribution of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr Virus restricted latency. J Virol 86:1034–1045
32. Ren L, Wang Y, Shi M, Wang X, Yang Z, Zhao Z (2012) CTCF mediates the cell-type specifi c spatial organization of the Kcnq5 locus and the local gene regulation. PLoS One 7:e31416
33. Jackson AL, Burchard J, Leake D, Reynolds A, Schelter J, Guo J et al (2006) Position-specifi c chemical modifi cation increases specifi city of siRNA-mediated gene silencing. RNA 12: 1197–1205
34. Chen PY, Weinmann L, Gaidatzis D, Pei Y, Zavolan M, Tuschl T et al (2008) Strandspecifi c 5′O-methylation of siRNA duplexes controls guide strand selection and target specifi city. RNA 2:263–274
35. Birmingham A, Anderson EM, Reynolds A, Ilsley-Tyree D, Leake D, Fedorov Y et al (2006) 3′-UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods 3:199–204
36. Anderson EM, Birmingham A, Baskerville S, Reynolds A, Maksimova E, Leake D et al (2008) Experimental validation of the importance of seed frequency to siRNA specifi city. RNA 14:853–861
37. Hou C, Zhao H, Tanimoto K, Dean A (2008) CTCF-dependent enhancer-blocking by alter-native chromatin loop formation. Proc Natl Acad Sci USA 105:20398–20403
38. Balakrishnan S, Witcher M, Berggren T, Emerson B (2012) Functional and molecular characterization of the role of CTCF in human embryonic stem cell biology. PloS One 7:e42424
39. Klimatcheva E, Ronsenblatt JD, Planelles V (1999) Lentiviral vectors and gene therapy. Front Biosci 4:D481–96
40. Biasco L, Baricordi C, Aiuti A (2012) Retroviral integrations in gene therapy trials. Mol Ther 20:709–716
41. Markusic D, Seppen J (2010) Doxycycline regulated lentiviral vectors. Methods Mol Biol 614:69–76
42. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline- responsive promoters. Proc Natl Acad Sci USA 89:5547–5551
43. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W (2000) Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 97:7963–7968
44. Zeng Y, Wagner EJ, Cullen BR (2002) Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell 9:1327–1333
45. DharmaFECT General Transfection Protocol, Dharmacon Inc. 2006, 00033–05-F-03-U
46. Ambion by Life Technologies, Silencer Select Pre- designed, Validated and Custom Designed siRNA, Custom Select siRNA, Ambion In Vivo Pre-designed, Custom Designed and Custom siRNA, 2011, Insert PN4457171 Rev B http://www.invitrogen.com/site/us/en/home/Products-and-Services/Applications/rnai/Synthetic-RNAi-Analysis/Ambion-Silencer-Select-siRNAs/silencer-select-sirna.html.html